IDH-mutated diffuse gliomas are often further subdivided into molecular astrocytomas (i.e. those with mutations in ATRX and/or TP53) and molecular oligodendrogliomas (i.e. those with 1p19q codeletion) [16, 23]. This evidence concerns the gene IDH2 and oligodendroglioma.